Non-ST-elevation myocardial infarction: dual etiology, twoway therapy

In regularly updated myocardial infarction guidelines, infarctions, including non-ST-elevation myocardial infarction (NSTEMI), were classified into 5 etiological groups, but not all characteristic features of NSTEMI can be explained in all groups (myocardial necrosis occurs without ST-elevation; pro...

Full description

Saved in:
Bibliographic Details
Main Authors: Mihály Medvegy, Nóra Medvegy
Format: Article
Language:English
Published: Promenade Kft 2025-07-01
Series:Cardiologia Hungarica
Subjects:
Online Access:https://cardiologia.hungarica.eu/archive/2025-issues/2025-3-contents/non-st-elevation-myocardial-infarction-dual-etiology-twoway-therapy
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849410065670340608
author Mihály Medvegy
Nóra Medvegy
author_facet Mihály Medvegy
Nóra Medvegy
author_sort Mihály Medvegy
collection DOAJ
description In regularly updated myocardial infarction guidelines, infarctions, including non-ST-elevation myocardial infarction (NSTEMI), were classified into 5 etiological groups, but not all characteristic features of NSTEMI can be explained in all groups (myocardial necrosis occurs without ST-elevation; prognosis is poor; connection with stress; anxiolytic/antidepressant administration is useful). Objective: To refine pathophysiology and to find an etiological explanation for the properties of NSTEMI. Method: Literature research was conducted on NSTEMI, fluid flow, microvascular dysfunction (MD) and sympathicotonia. Results/information: Proven properties of NSTEMI: electrical potential loss can be detected and localized; the one-year mortality is higher compared to ST-elevation myocardial infarction; enzyme kinetics are uneven and prolonged; administration of antidepressants/anxiolytics and early intervention in culprit lesions are beneficial. The information obtained on the basis of the law of fluid flow: in a closed pipe, the flow-reducing effect of successive constrictions is cumulated. Information about MD: it is a consequence of various clinical pathologies; it can cause severe myocardial ischemia or infarction even without coronary artery disease (CAD); its quantitative determination is recommended – mainly in non-obstructive CAD; stress/sympathicotonia can acutely worsen MD and increase the incidence of myocardial infarctions in the case of earthquake, stroke, depression, anxiety, persistent pain, cancer, extreme physical exertion. Elevated blood sugar levels (which indicate sympathicotonia, but also worsen MD) indicate a poor prognosis. Conclusion: All the characteristics of NSTEMI can be explained by the dual etiology that is valid in all groups and is inferred from the above data: "NSTEMI is caused by the acute deterioration of one of two concomitant pathologies (MD/generalized hypoxia and CAD)". MD deterioration is triggered by various acute stressors, most often sympathetic tone enhancement (stress). There is no ST-elevation, because even in spite of obstructive CAD, the blood supply to the subepicardium is still sufficient. The dual etiology is evidenced by the fact that both the improvement of CAD and the reduction of hypoxia/sympathicotonia have a beneficial effect, so both causes must be treated.
format Article
id doaj-art-4e3f92e98a734f99925291633b50c401
institution Kabale University
issn 0133-5596
1588-0230
language English
publishDate 2025-07-01
publisher Promenade Kft
record_format Article
series Cardiologia Hungarica
spelling doaj-art-4e3f92e98a734f99925291633b50c4012025-08-20T03:35:16ZengPromenade KftCardiologia Hungarica0133-55961588-02302025-07-0155317618310.26430/CHUNGARICA.2025.55.3.176Non-ST-elevation myocardial infarction: dual etiology, twoway therapyMihály Medvegy0Nóra Medvegy1Flór Ferenc Hospital, Cardiology Department, KistarcsaEgis Pharmaceuticals Plc., BudapestIn regularly updated myocardial infarction guidelines, infarctions, including non-ST-elevation myocardial infarction (NSTEMI), were classified into 5 etiological groups, but not all characteristic features of NSTEMI can be explained in all groups (myocardial necrosis occurs without ST-elevation; prognosis is poor; connection with stress; anxiolytic/antidepressant administration is useful). Objective: To refine pathophysiology and to find an etiological explanation for the properties of NSTEMI. Method: Literature research was conducted on NSTEMI, fluid flow, microvascular dysfunction (MD) and sympathicotonia. Results/information: Proven properties of NSTEMI: electrical potential loss can be detected and localized; the one-year mortality is higher compared to ST-elevation myocardial infarction; enzyme kinetics are uneven and prolonged; administration of antidepressants/anxiolytics and early intervention in culprit lesions are beneficial. The information obtained on the basis of the law of fluid flow: in a closed pipe, the flow-reducing effect of successive constrictions is cumulated. Information about MD: it is a consequence of various clinical pathologies; it can cause severe myocardial ischemia or infarction even without coronary artery disease (CAD); its quantitative determination is recommended – mainly in non-obstructive CAD; stress/sympathicotonia can acutely worsen MD and increase the incidence of myocardial infarctions in the case of earthquake, stroke, depression, anxiety, persistent pain, cancer, extreme physical exertion. Elevated blood sugar levels (which indicate sympathicotonia, but also worsen MD) indicate a poor prognosis. Conclusion: All the characteristics of NSTEMI can be explained by the dual etiology that is valid in all groups and is inferred from the above data: "NSTEMI is caused by the acute deterioration of one of two concomitant pathologies (MD/generalized hypoxia and CAD)". MD deterioration is triggered by various acute stressors, most often sympathetic tone enhancement (stress). There is no ST-elevation, because even in spite of obstructive CAD, the blood supply to the subepicardium is still sufficient. The dual etiology is evidenced by the fact that both the improvement of CAD and the reduction of hypoxia/sympathicotonia have a beneficial effect, so both causes must be treated.https://cardiologia.hungarica.eu/archive/2025-issues/2025-3-contents/non-st-elevation-myocardial-infarction-dual-etiology-twoway-therapynon-st-elevation myocardial infarctionpathophysiologysympathicotoniamicrovascular dysfunction
spellingShingle Mihály Medvegy
Nóra Medvegy
Non-ST-elevation myocardial infarction: dual etiology, twoway therapy
Cardiologia Hungarica
non-st-elevation myocardial infarction
pathophysiology
sympathicotonia
microvascular dysfunction
title Non-ST-elevation myocardial infarction: dual etiology, twoway therapy
title_full Non-ST-elevation myocardial infarction: dual etiology, twoway therapy
title_fullStr Non-ST-elevation myocardial infarction: dual etiology, twoway therapy
title_full_unstemmed Non-ST-elevation myocardial infarction: dual etiology, twoway therapy
title_short Non-ST-elevation myocardial infarction: dual etiology, twoway therapy
title_sort non st elevation myocardial infarction dual etiology twoway therapy
topic non-st-elevation myocardial infarction
pathophysiology
sympathicotonia
microvascular dysfunction
url https://cardiologia.hungarica.eu/archive/2025-issues/2025-3-contents/non-st-elevation-myocardial-infarction-dual-etiology-twoway-therapy
work_keys_str_mv AT mihalymedvegy nonstelevationmyocardialinfarctiondualetiologytwowaytherapy
AT noramedvegy nonstelevationmyocardialinfarctiondualetiologytwowaytherapy